Cite
Benucci M, Meacci F, Grossi V, et al. Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab. Biologics. 2016;10:53-8doi: 10.2147/BTT.S97234.
Benucci, M., Meacci, F., Grossi, V., Infantino, M., Manfredi, M., Bellio, E., Bellio, V., Li Gobbi, F., Bazzichi, L., Moscato, P., Caputo, D., Saviola, G., Talotta, R., Sarzi-Puttini, P., & Atzeni, F. (2016). Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab. Biologics : targets & therapy, 1053-8. https://doi.org/10.2147/BTT.S97234
Benucci, Maurizio, et al. "Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab." Biologics : targets & therapy vol. 10 (2016): 53-8. doi: https://doi.org/10.2147/BTT.S97234
Benucci M, Meacci F, Grossi V, Infantino M, Manfredi M, Bellio E, Bellio V, Li Gobbi F, Bazzichi L, Moscato P, Caputo D, Saviola G, Talotta R, Sarzi-Puttini P, Atzeni F. Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab. Biologics. 2016 Mar 11;10:53-8. doi: 10.2147/BTT.S97234. eCollection 2016. PMID: 27041992; PMCID: PMC4795572.
Copy
Download .nbib